Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector

Future Microbiology

Volumn 8, Issue 1, 2013, Pages 41-56

  Kung, Faith ^a   Anguita, Juan ^b,c   Pal, Utpal ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b CIC BIOGUNE   (Spain)

^c BASQUE FOUNDATION FOR SCIENCE   (Spain)

Author keywords

Borrelia burgdorferi; Ixodes ticks; Lyme disease; vector pathogen interaction

Indexed keywords

BACTERIAL PROTEIN; DPS PROTEIN; LIPOPROTEIN; OUTER MEMBRANE PROTEIN; PROTEIN BBA52; PROTEIN BBA64; PROTEIN BMTA; PROTEIN VISE; UNCLASSIFIED DRUG;

BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BORRELIA BURGDORFERI; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; HOST PATHOGEN INTERACTION; IXODES; IXODES SCAPULARIS; LYME DISEASE; MOLECULAR GENETICS; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; SPIROCHETE;

ANIMALS; ARACHNID VECTORS; ARTHROPOD PROTEINS; BORRELIA BURGDORFERI; HOST-PATHOGEN INTERACTIONS; HUMANS;

BORRELIA BURGDORFERI; IXODES; IXODES SCAPULARIS; IXODIDA; SPIROCHAETALES;

EID: 84871458941     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.121     Document Type: Review

References (217)

1. Piesman J, Eisen L. Prevention of tick-borne diseases. Annu. Rev. Entomol. 53, 323-343 (2008
2. Piesman J, Gern L. Lyme borreliosis in Europe and North America. Parasitology 129 Suppl, S191-S220 (2004
3. Rizzoli A, Hauffe H, Carpi G, Vourc HG, Neteler M, Rosa R. Lyme borreliosis in Europe. Euro Surveill. 16(27), 19906 (2011
4. Levi T, Kilpatrick AM, Mangel M, Wilmers CC. Deer, predators, and the emergence of Lyme disease. Proc. Natl Acad. Sci. USA 109(27), 10942-10947 (2012
5. Anderson J. Epizootiology of Lyme borreliosis. Scan. J. Infect. Dis. 77, 23-24 (1991
6. Anguita J, Hedrick MN, Fikrig E. Adaptation of Borrelia burgdorferi in the tick and the mammalian host. FEMS Microbiol. Rev. 27(4), 493-504 (2003
7. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwalt E, Davis JP. Lyme disease - A tickborne spirochetosis? Science 216, 1317-1319 (1982
8. Pal U, Fikrig E. Adaptation of Borrelia burgdorferi in the vector and vertebrate host. Microbes Infect. 5(7), 659-666 (2003
9. Radolf JD, Caimano MJ, Stevenson B, Hu LT. Of ticks, mice and men: Understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat. Rev. Microbiol. 10(2), 87-99 (2012
10. Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet 379(9814), 461-473 (2012
11. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J. Clin. Invest. 113(8), 1093-1101 (2004
12. Tilly K, Rosa PA, Stewart PE. Biology of infection with Borrelia burgdorferi. Infect. Dis. Clin. North Am. 22(2), 217-234, (2008
13. Barthold SW, Beck DS, Hansen GM, Terwilliger GA, Moody KD. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162, 133-138 (1990
14. Barthold SW, Desouza MS, Janotka JL, Smith AL, Persing DH. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143, 959-971 (1993
15. Barthold SW, Diego C, Philipp MT. Animal models of borreliosis. In: Borrelia, Molecular Biology, Host Interaction and Pathogenesis. Samuels DS, Radolf JD (Eds). Caister Academic Press, UK, 353-405 (2010
16. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 352(9127), 557-565 (1998
17. Radolf JD, Salazar JC, Dattwyler RJ. Lyme disease in humans. In: Borrelia, Molecular Biology, Host Interaction and Pathogenesis. Samuels DS, Radolf JD (Eds). Caister Academic Press, UK, 487-533 (2010
18. Steere AC, Glickstein L. Elucidation of Lyme arthritis. Nat. Rev. Immunol. 4(2), 143-152 (2004
19. de Silva AM, Tyson KR, Pal U. Molecular characterization of the tick-Borrelia interface. Front. Biosci. 14, 3051-3063 (2009
20. Pal U, Fikrig E. Tick interactions. In: Borrelia, Molecular Biology, Host Interaction and Pathogenesis. Samuels DS, Radolf JD (Eds). Caister Academic Press, UK, 279-298 (2010
21. Nava S, Guglielmone AA, Mangold AJ. An overview of systematics and evolution of ticks. Front. Biosci. 14, 2857-2877 (2009
22. Rosa PA, Tilly K, Stewart PE. The burgeoning molecular genetics of the Lyme disease spirochaete. Nat. Rev. Microbiol. 3(2), 129-143 (2005
23. de la Fuente J, Kocan KM, Almazan C, Blouin EF. RNA interference for the study and genetic manipulation of ticks. Trends Parasitol. 23(9), 427-433 (2007
24. Hill CA, Wikel SK. The Ixodes scapularis genome project: An opportunity for advancing tick research. Trends Parasitol. 21(4), 151-153 (2005
25. Nene V. Tick genomics - coming of age. Front. Biosci. 14, 2666-2673 (2009
26. Pagel Van Zee J, Geraci NS, Guerrero FD et al. Tick genomics: The Ixodes genome project and beyond. Int. J. Parasitol. 37(12), 1297-1305 (2007
27. Marconi RT, Earnhart CG. Lyme disease vaccines. In: Borrelia, Molecular Biology, Host Interaction and Pathogenesis. Samuels DS, Radolf JD (Eds). Caister Academic Press, UK, 467-486 (2010
28. Schwan TG, Piesman J. Vector interactions and molecular adaptations of Lyme disease and relapsing fever spirochetes associated with transmission by ticks. Emerg. Infect. Dis. 8(2), 115-121. (2002
29. Coburn J, Fischer JR, Leong JM. Solving a sticky problem: New genetic approaches to host cell adhesion by the Lyme disease spirochete. Mol. Microbiol. 57(5), 1182-1195 (2005
30. Fikrig E, Narasimhan S. Borrelia burgdorferi - Traveling incognitö Microbes Infect. 8(5), 1390-1399 (2006
31. Hu LT, Klempner MS. Host-pathogen interactions in the immunopathogenesis of Lyme disease. J. Clin. Immunol. 17(5), 354-365 (1997
32. Pal U, Anderson JF, Fikrig E. Borrelia burgdorferi and Ixodes scapularis: Exploring the pathogen-vector interface. In: Molecular Biology of Spirochetes. Cabello FC, Hulinska D, Godfrey HP (Eds). IOS press, The Netherlands, 345-353 (2006
33. Hovius JW, Van Dam AP, Fikrig E. Tick-host-pathogen interactions in Lyme borreliosis. Trends Parasitol. 23(9), 434-438 (2007
34. Tyson KR, Piesman J. Lyme disease spirochete-Tick-host interactions. Adv. Insect Physiol. 37, 243-296 (2009
35. Nascimento AL, Verjovski-Almeida S, Van Sluys MA et al. Genome features of Leptospira interrogans serovar Copenhageni. Braz. J. Med. Biol. Res. 37(4), 459-477 (2004
36. Porcella SF, Schwan TG. Borrelia burgdorferi and Treponema pallidum: A comparison of functional genomics, environmental adaptations, and pathogenic mechanisms. J. Clin. Invest. 107(6), 651-656 (2001
37. Subramanian G, Koonin EV, Aravind L. Comparative genome analysis of the pathogenic spirochetes Borrelia burgdorferi and Treponema pallidum. Infect. Immun. 68(3), 1633-1648 (2000
38. Schleifer KH, Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36(4), 407-477 (1972
39. Bergström S, Zückert WR. Structure, Function and biogenesis of the Borrelia cell envelope. In: Borrelia, Molecular Biology, Host Interaction and Pathogenesis. Samuels DS, Radolf JD (Eds). Caister Academic Press, UK, 139-166 (2010
40. Casjens S, Palmer N, Van Vugt R et al. A bacterial genome in flux: The twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferfi. Mol. Microbiol. 35(3), 490-516 (2000
41. Fraser CM, Casjens S, Huang WM et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390(6660), 580-586 (1997
42. de Silva AM, Fikrig E. Arthropod- And host-specific gene expression by Borrelia burgdorferi. J. Clin. Invest. 99(3), 377-379 (1997
43. Samuels DS. Gene regulation in Borrelia burgdorferi. Annu. Rev. Microbiol. 65, 479-499 (2011
44. Zhang JR, Hardham JM, Barbour AG, Norris SJ. Antigenic variation in Lyme disease Borreliae by promiscuous recombination of Vmp-like sequence cassettes. Cell 89(2), 275-285 (1997
45. Zhang JR, Norris SJ. Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion. Infect. Immun. 66(8), 3698-3704 (1998
46. Munderloh UG, Kurtti TJ. Cellular and molecular interrelationships between ticks and prokaryotic tick-borne pathogens. Annu. Rev. Entomol. 40, 221-243 (1995
47. de Silva AM, Fikrig E. Growth and migration of Borrelia burgdorferi in Ixodes ticks during blood feeding. Am. J. Trop. Med. Hyg. 53(4), 397-404 (1995
48. Anderson JF, Duray PH, Magnarelli LA. Prevalence of Borrelia burgdorferi in white-footed mice and Ixodes dammini at Fort McCoy, Wis. J. Clin. Microbiol. 25(8), 1495-1497 (1987
49. Logiudice K, Ostfeld RS, Schmidt KA, Keesing F. The ecology of infectious disease: Effects of host diversity and community composition on Lyme disease risk. Proc. Natl Acad. Sci. USA 100(2), 567-571 (2003
50. Brisson D, Dykhuizen DE. ospC diversity in Borrelia burgdorferi: Different hosts are different niches. Genetics 168(2), 713-722 (2004
51. Hanincova K, Kurtenbach K, Diuk-Wasser M, Brei B, Fish D. Epidemic spread of Lyme borreliosis, northeastern United States. Emerg. Infect. Dis. 12(4), 604-611 (2006
52. Brisson D, Dykhuizen DE, Ostfeld RS. Conspicuous impacts of inconspicuous hosts on the Lyme disease epidemic. Proc. Biol. Sci. 275(1631), 227-235 (2008
53. Brisson D, Dykhuizen DE. A modest model explains the distribution and abundance of Borrelia burgdorferi strains. Am. J. Trop. Med. Hyg. 74(4), 615-622 (2006
54. Promnares K, Kumar M, Shroder DY, Zhang X, Anderson JF, Pal U. Borrelia burgdorferi small lipoprotein Lp6.6 is a member of multiple protein complexes in the outer membrane and facilitates pathogen transmission from ticks to mice. Mol. Microbiol. 74(1), 112-125 (2009
55. Osta MA, Christophides GK, Kafatos FC. Effects of mosquito genes on Plasmodium development. Science 303(5666), 2030-2032 (2004
56. Sinden RE. Molecular interactions between Plasmodium and its insect vectors. Cell Microbiol. 4(11), 713-724 (2002
57. Pal U, Montgomery RR, Lusitani D et al. Inhibition of Borrelia burgdorferi-Tick interactions in vivo by outer surface protein A antibody. J. Immunol. 166(12), 7398-7403 (2001
58. Sonenshine DE. Biology of Ticks, Volume 1. Oxford University Press, NY, USA (1993
59. Wickramasekara S, Bunikis J, Wysocki V, Barbour AG. Identification of residual blood proteins in ticks by mass spectrometry proteomics. Emerg. Infect. Dis. 14(8), 1273-1275 (2008
60. Ohnishi J, Piesman J, de Silva AM. Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc. Natl Acad. Sci. USA 98(2), 670-675 (2001
61. Piesman J. Dynamics of Borrelia burgdorferi transmission by nymphal Ixodes dammini ticks. J. Infect. Dis. 167, 1082-1085 (1993
62. Piesman J, Schneider BS, Zeidner NS. Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors. J. Clin. Microbiol. 39(11), 4145-4148 (2001
63. Dunham-Ems SM, Caimano MJ, Pal U et al. Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks. J. Clin. Invest. 119(12), 3652-3665 (2009
64. Coleman JL, Gebbia JA, Piesman J, Degen JL, Bugge TH, Benach JL. Plasminogen is required for efficient dissemination of Borrelia burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell 89, 1111-1119 (1997
65. Fingerle V, Goettner G, Gern L, Wilske B, Schulte-Spechtel U. Complementation of a Borrelia afzelii OspC mutant highlights the crucial role of OspC for dissemination of Borrelia afzelii in Ixodes ricinus. Int. J. Med. Microbiol. 297(2), 97-107 (2007
66. Kumar M, Yang X, Coleman AS, Pal U. BBA52 facilitates Borrelia burgdorferi transmission from feeding ticks to murine hosts. J. Infect. Dis. 201(7), 1084-1095 (2010
67. Pal U, Yang X, Chen M et al. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J. Clin. Invest. 113(2), 220-230 (2004
68. Zhang L, Zhang Y, Adusumilli S et al. Molecular interactions that enable movement of the Lyme disease agent from the tick gut into the hemolymph. Plos Pathog. 7(6), e1002079 (2011
69. Dunham-Ems SM, Caimano MJ, Eggers CH, Radolf JD. Borrelia burgdorferi requires the alternative sigma factor RpoS for dissemination within the vector during tick-To-mammal transmission. Plos Pathog. 8(2), e1002532 (2012
70. Grimm D, Eggers CH, Caimano MJ et al. Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle. Infect. Immun. 72(10), 5938-5946 (2004
71. Labandeira-Rey M, Skare JT. Decreased infectivity in Borrelia burgdorferi strain B31 is associated with loss of linear plasmid 25 or 28-21. Infect. Immun. 69(1), 446-455 (2001
72. Purser JE, Lawrenz MB, Caimano MJ, Howell JK, Radolf JD, Norris SJ. A plasmid-encoded nicotinamidase (PncA) is essential for infectivity of Borrelia burgdorferi in a mammalian host. Mol. Microbiol. 48(3), 753-764 (2003
73. Purser JE, Norris SJ. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl Acad. Sci. USA 97(25), 13865-13870 (2000
74. Strother KO, Broadwater A, de Silva A. Plasmid requirements for infection of ticks by Borrelia burgdorferi. Vector Borne Zoonotic Dis. 5(3), 237-245 (2005
75. Strother KO, de Silva A. Role of Borrelia burgdorferi linear plasmid 25 in infection of Ixodes scapularis ticks. J. Bacteriol. 187(16), 5776-5781 (2005
76. Jewett MW, Lawrence K, Bestor AC et al. The critical role of the linear plasmid lp36 in the infectious cycle of Borrelia burgdorferi. Mol. Microbiol. 64(5), 1358-1374 (2007
77. Boardman BK, He M, Ouyang Z, Xu H, Pang X, Yang XF. Essential role of the response regulator Rrp2 in the infectious cycle of Borrelia burgdorferi. Infect. Immun. 76(9), 3844-3853 (2008
78. Caimano MJ, Iyer R, Eggers CH et al. Analysis of the RpoS regulon in Borrelia burgdorferi in response to mammalian host signals provides insight into RpoS function during the enzootic cycle. Mol. Microbiol. 65(5), 1193-1217 (2007
79. Fisher MA, Grimm D, Henion AK et al. Borrelia burgdorferi sigma54 is required for mammalian infection and vector transmission but not for tick colonization. Proc. Natl Acad. Sci. USA 102(14), 5162-5167 (2005
80. Hubner A, Yang X, Nolen DM, Popova TG, Cabello FC, Norgard MV. Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc. Natl Acad. Sci. USA 98(22), 12724-12729 (2001
81. Ouyang Z, Blevins JS, Norgard MV. Transcriptional interplay among the regulators Rrp2, RpoN and RpoS in Borrelia burgdorferi. Microbiology 154(PT9), 2641-2658 (2008
82. Ouyang Z, Narasimhan S, Neelakanta G et al. Activation of the RpoN-RpoS regulatory pathway during the enzootic life cycle of Borrelia burgdorferi. BMC Microbiol. 12, 44 (2012
83. Yang XF, Alani SM, Norgard MV. The response regulator Rrp2 is essential for the expression of major membrane lipoproteins in Borrelia burgdorferi. Proc. Natl Acad. Sci. USA 100(19), 11001-11006 (2003
84. Xu H, Caimano MJ, Lin T et al. Role of acetyl-phosphate in activation of the Rrp2- RpoN-RpoS pathway in Borrelia burgdorferi. Plos Pathog. 6(9), e1001104 (2010
85. Groshong AM, Gibbons NE, Yang XF, Blevins JS. Rrp2, a prokaryotic enhancer-like binding protein, is essential for viability of Borrelia burgdorferi. J. Bacteriol. 194(13), 3336-3342 (2012
86. Hyde JA, Shaw DK, Smith R III, Trzeciakowski JP, Skare JT. The BosR regulatory protein of Borrelia burgdorferi interfaces with the RpoS regulatory pathway and modulates both the oxidative stress response and pathogenic properties of the Lyme disease spirochete. Mol. Microbiol. 74(6), 1344-1355 (2009
87. Hyde JA, Shaw DK, Smith III R, Trzeciakowski JP, Skare JT. Characterization of a conditional bosR mutant in Borrelia burgdorferi. Infect. Immun. 78(1), 265-274 (2009
88. Ouyang Z, Deka RK, Norgard MV. BosR (BB0647) controls the RpoN-RpoS regulatory pathway and virulence expression in Borrelia burgdorferi by a novel DNA-binding mechanism. Plos Pathog. 7(2), e1001272 (2011
89. Ouyang Z, Kumar M, Kariu T et al. BosR (BB0647) governs virulence expression in Borrelia burgdorferi. Mol. Microbiol. 74(6), 1331-1343 (2009
90. Samuels DS, Radolf JD. Who is the BosR around here anyway? Mol. Microbiol. 74(6), 1295-1299 (2009
91. Karna SL, Sanjuan E, Esteve-Gassent MD, Miller CL, Maruskova M, Seshu J. CsrA modulates levels of lipoproteins and key regulators of gene expression critical for pathogenic mechanisms of Borrelia burgdorferi. Infect. Immun. 79(2), 732-744 (2011
92. Sze CW, Li C. Inactivation of bb0184, which encodes carbon storage regulator A, represses the infectivity of Borrelia burgdorferi. Infect. Immun. 79(3), 1270-1279 (2011
93. Sanjuan E, Esteve-Gassent MD, Maruskova M, Seshu J. Overexpression of CsrA (BB0184) alters the morphology and antigen profiles of Borrelia burgdorferi. Infect. Immun. 77(11), 5149-5162 (2009
94. Motaleb MA, Corum L, Bono JL et al. Borrelia burgdorferi periplasmic flagella have both skeletal and motility functions. Proc. Natl Acad. Sci. USA 97(20), 10899-10904 (2000
95. Lybecker MC, Samuels DS. Temperature-induced regulation of RpoSby a small RNA in Borrelia burgdorferi. Mol. Microbiol. 64(4), 1075-1089 (2007
96. Caimano MJ, Kenedy MR, Kairu T et al. The hybrid histidine kinase Hk1 is part of a two-component system that is essential for survival of Borrelia burgdorferi in feeding Ixodes scapularis ticks. Infect. Immun. 79(8), 3117-3130 (2011
97. Freedman JC, Rogers EA, Kostick JL et al. Identification and molecular characterization of a cyclic-di-GMP effector protein, PlzA (BB0733). additional evidence for the existence of a functional cyclic-di-GMP regulatory network in the Lyme disease spirochete, Borrelia burgdorferi. FEMS Immunol. Med. Microbiol. 58(2), 285-294 (2010
98. He M, Ouyang Z, Troxell B et al. Cyclic di- GMP is essential for the survival of the Lyme disease spirochete in ticks. Plos Pathog. 7(6), e1002133 (2011
99. Rogers EA, Terekhova D, Zhang HM, Hovis KM, Schwartz I, Marconi RT. Rrp1, a cyclic-di- GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functions. Mol. Microbiol. 71(6), 1551-1573 (2009
100. Kostick JL, Szkotnicki LT, Rogers EA, Bocci P, Raffaelli N, Marconi RT. The diguanylate cyclase, Rrp1, regulates critical steps in the enzootic cycle of the Lyme disease spirochetes. Mol. Microbiol. 81(1), 219-231 (2011
101. Pappas CJ, Iyer R, Petzke MM, Caimano MJ, Radolf JD, Schwartz I. Borrelia burgdorferi requires glycerol for maximum fitness during the tick phase of the enzootic cycle. Plos Pathog. 7(7), e1002102 (2011
102. Sultan SZ, Pitzer JE, Boquoi T, Hobbs G, Miller MR, Motaleb MA. Analysis of the HD-GYP domain cyclic dimeric GMP phosphodiesterase reveals a role in motility and the enzootic life cycle of Borrelia burgdorferi. Infect. Immun. 79(8), 3273-3283 (2011
103. Pitzer JE, Sultan SZ, Hayakawa Y, Hobbs G, Miller MR, Motaleb MA. Analysis of the Borrelia burgdorferi cyclic-di-GMP-binding protein PlzA reveals a role in motility and virulence. Infect. Immun. 79(5), 1815-1825 (2011
104. Sultan SZ, Pitzer JE, Miller MR, Motaleb MA. Analysis of a Borrelia burgdorferi phosphodiesterase demonstrates a role for cyclic-di-guanosine monophosphate in motility and virulence. Mol. Microbiol. 77(1), 128-142 (2010
105. Sze CW, Zhang K, Kariu T, Pal U, Li C. Borrelia burgdorferi needs chemotaxis to establish infection in mammals and to accomplish its enzootic cycle. Infect. Immun. 80(7), 2485-2492 (2012
106. Neelakanta G, Li X, Pal U et al. Outer surface protein B is critical for Borrelia burgdorferi adherence and survival within Ixodes ticks. Plos Pathog. 3(3), e33 (2007
107. Pal U, De Silva AM, Montgomery RR et al. Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J. Clin. Invest. 106(4), 561-569 (2000
108. Yang XF, Pal U, Alani SM, Fikrig E, Norgard MV. Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J. Exp. Med. 199(5), 641-648 (2004
109. Pal U, Li X, Wang T et al. TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell 119(4), 457-468 (2004
110. Fuchs H, Wallich R, Simon MM, Kramer MD. The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen receptor. Proc. Natl Acad. Sci. USA 91(26), 12594-12598 (1994
111. Battisti JM, Bono JL, Rosa PA, Schrumpf ME, Schwan TG, Policastro PF. Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector. Infect. Immun. 76, 5228-5237 (2008
112. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc. Natl Acad. Sci. USA 92(7), 2909-2913 (1995
113. Grimm D, Tilly K, Byram R et al. Outer-surface protein C of the Lyme disease spirochete: A protein induced in ticks for infection of mammals. Proc. Natl Acad. Sci. USA 101(9), 3142-3147 (2004
114. Lagal V, Portnoi D, Faure G, Postic D, Baranton G. Borrelia burgdorferi sensu stricto invasiveness is correlated with OspC-plasminogen affinity. Microbes Infect. 8(3), 645-652 (2006
115. Onder O, Humphrey PT, McOmber B et al. OspC is potent plasminogen receptor on surface of Borrelia burgdorferi. J. Biol. Chem. 287(20), 16860-16868 (2012
116. Li X, Neelakanta G, Liu X et al. Role of outer surface protein D in the Borrelia burgdorferi life cycle. Infect. Immun. 75(9), 4237-4244 (2007
117. Stewart PE, Bestor A, Cullen JN, Rosa PA. A tightly regulated surface protein of Borrelia burgdorferi is not essential to the mouse-Tick infectious cycle. Infect. Immun. 76(5), 1970-1978 (2008
118. Li X, Pal U, Ramamoorthi N et al. The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks. Mol. Microbiol. 63(3), 694-710 (2007
119. Codolo G, Papinutto E, Polenghi A, D'elios MM, Zanotti G, De Bernard M. Structure and immunomodulatory property relationship in NapA of Borrelia burgdorferi. Biochim Biophys Acta 1804(12), 2191-2197 (2010
120. Coutte L, Botkin DJ, Gao L, Norris SJ. Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection. Plos Pathog. 5(2), e1000293 (2009
121. Lin T, Gao L, Edmondson DG, Jacobs MB, Philipp MT, Norris SJ. Central role of the Holliday junction helicase RuvAB in vlsE recombination and infectivity of Borrelia burgdorferi. Plos Pathog. 5(12), e1000679 (2009
122. Palmer GH, Bankhead T, Lukehart SA. 'Nothing is permanent but change'- Antigenic variation in persistent bacterial pathogens. Cell Microbiol. 11(12), 1697-1705 (2009
123. Zhang JR, Norris SJ. Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect. Immun. 66(8), 3689-3697 (1998
124. Ohnishi J, Schneider B, Messer WB, Piesman J, De Silva AM. Genetic variation at the vlsE locus of Borrelia burgdorferi within ticks and mice over the course of a single transmission cycle. J. Bacteriol. 185(15), 4432-4441 (2003
125. Lahdenne P, Porcella SF, Hagman KE et al. Molecular characterization of a 6.6-kilodalton Borrelia burgdorferi outer membrane-associated lipoprotein (lp6.6) which appears to be downregulated during mammalian infection. Infect. Immun. 65(2), 412-421 (1997
126. Yang X, Promnares K, Qin J et al. Characterization of multiprotein complexes of the Borrelia burgdorferi outer membrane vesicles. J. Proteome Res. 10(10), 4556-4566 (2011
127. Pal U, Dai J, Li X et al. A differential role for BB0365 in the persistence of Borrelia burgdorferi in mice and ticks. J. Infect. Dis. 197(1), 148-155 (2008
128. Revel AT, Blevins JS, Almazan C et al. bptA (bbe16) is essential for the persistence of the Lyme disease spirochete, Borrelia burgdorferi, in its natural tick vector. Proc. Natl Acad. Sci. USA 102(19), 6972-6977 (2005
129. Xu H, He M, He JJ, Yang XF. Role of the surface lipoprotein BBA07 in the enzootic cycle of Borrelia burgdorferi. Infect. Immun. 78(7), 2910-2918 (2010
130. Bykowski T, Woodman ME, Cooley AE et al. Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete's mammal-Tick infection cycle. Infect. Immun. 75(9), 4227-4236 (2007
131. Bykowski T, Woodman ME, Cooley AE et al. Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs). Expression patterns during the mammal-Tick infection cycle. Int. J. Med. Microbiol. 298(SUPPL1), 249-256 (2007
132. Coleman AS, Yang X, Kumar M et al. Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity. Plos One 3(8), e3010 (2008
133. Mcdowell JV, Hovis KM, Zhang H, Tran E, Lankford J, Marconi RT. Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals. Infect. Immun. 74(5), 3030-3034 (2006
134. Stewart PE, Hoff J, Fischer E, Krum JG, Rosa PA. Genome-wide transposon mutagenesis of Borrelia burgdorferi for identification of phenotypic mutants. Appl. Environ. Microbiol. 70(10), 5973-5979 (2004
135. Zhang X, Yang X, Kumar M, Pal U. BB0323 function is essential for Borrelia burgdorferi virulence and persistence through tick-rodent transmission cycle. J. Infect. Dis. 200(8), 1318-1330 (2009
136. Kumar M, Kaur S, Kariu T et al. Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine. Vaccine 29(48), 9012-9019 (2011
137. Gilmore RD Jr, Howison RR, Dietrich G, Patton TG, Clifton DR, Carroll JA. The bba64 gene of Borrelia burgdorferi, the Lyme disease agent, is critical for mammalian infection via tick bite transmission. Proc. Natl Acad. Sci. USA 107(16), 7515-7520 (2010
138. Ouyang Z, He M, Oman T, Yang XF, Norgard MV. A manganese transporter, BB0219 (BmtA), is required for virulence by the Lyme disease spirochete, Borrelia burgdorferi. Proc. Natl Acad. Sci. USA 106(9), 3449-3454 (2009
139. Eggers CH, Caimano MJ, Malizia R A et al. The coenzyme A disulphide reductase of Borrelia burgdorferi is important for rapid growth throughout the enzootic cycle and essential for infection of the mammalian host. Mol. Microbiol. 82(3), 679-697 (2011
140. Jewett MW, Lawrence KA, Bestor A, Byram R, Gherardini F, Rosa PA. GuaA and GuaB are essential for Borrelia burgdorferi survival in the tick-mouse infection cycle. J. Bacteriol. 191(20), 6231-6241 (2009
141. Floden AM, Watt JA, Brissette CA. Borrelia burgdorferi enolase is a surface-exposed plasminogen binding protein. Plos One 6(11), e27502 (2011
142. Toledo A, Coleman JL, Kuhlow CJ, Crowley JT, Benach JL. The enolase of Borrelia burgdorferi is a plasminogen receptor released in outer membrane vesicles. Infect. Immun. 80(1), 359-368 (2011
143. Nogueira SV, Smith A A, Qin JH, Pal U. A surface enolase participates in Borrelia burgdorferi-plasminogen interaction and contributes to pathogen survival within feeding ticks. Infect. Immun. 80(1), 82-90 (2011
144. Shaw DK, Hyde JA, Skare JT. The BB0646 protein demonstrates lipase and haemolytic activity associated with Borrelia burgdorferi, the aetiological agent of Lyme disease. Mol. Microbiol. 83(2), 319-334 (2012
145. Hubner A, Revel AT, Nolen DM, Hagman KE, Norgard MV. Expression of a luxS gene is not required for Borrelia burgdorferi infection of mice via needle inoculation. Infect. Immun. 71(5), 2892-2896 (2003
146. Tilly K, Grimm D, Bueschel DM, Krum JG, Rosa P. Infectious cycle analysis of a Borrelia burgdorferi mutant defective in transport of chitobiose, a tick cuticle component. Vector Borne Zoonotic Dis 4(2), 159-168 (2004
147. Hoon-Hanks LL, Morton EA, Lybecker MC, Battisti JM, Samuels DS, Drecktrah D. Borrelia burgdorferi malQ mutants utilize disaccharides and traverse the enzootic cycle. FEMS Immunol. Med. Microbiol. 66(2), 157-165 (2012
148. Banik S, Terekhova D, Iyer R et al. BB0844, an RpoS-regulated protein, is dispensable for Borrelia burgdorferi infectivity and maintenance in the mouse-Tick infectious cycle. Infect. Immun. 79(3), 1208-1217 (2011
149. Xu H, He M, Pang X, Xu ZC, Piesman J, Yang XF. Characterization of the highly regulated antigen BBA05 in the enzootic cycle of Borrelia burgdorferi. Infect. Immun. 78(1), 100-107 (2010
150. Bestor A, Stewart PE, Jewett MW, Sarkar A, Tilly K, Rosa PA. Use of the Cre-lox recombination system to investigate the lp54 gene requirement in the infectious cycle of Borrelia burgdorferi. Infect. Immun. 78(6), 2397-2407 (2010
151. de la Fuente J, Kocan KM, Almazan C, Blouin EF. Targeting the tick-pathogen interface for novel control strategies. Front. Biosci. 13, 6947-6956 (2008
152. de la Fuente J, Kocan KM, Blouin EF. Tick vaccines and the transmission of tick-borne pathogens. Vet. Res. Commun. 31(SUPPL1), 85-90 (2007
153. Munderloh UG, Kurtti TJ. The ABCs of Lyme disease spirochaetes in ticks. Lancet 366(9490), 962-964 (2005
154. Narasimhan S, Deponte K, Marcantonio N et al. Immunity against Ixodes scapularis salivary proteins expressed within 24 hours of attachment thwarts tick feeding and impairs Borrelia transmission. Plos One 2(5), e451 (2007
155. Ribeiro JM, Alarcon-Chaidez F, Francischetti IM et al. An annotated catalog of salivary gland transcripts from Ixodes scapularis ticks. Insect Biochem. Mol. Biol. 36(2), 111-129 (2006
156. Schuijt TJ, Narasimhan S, Daffre S et al. Identification and characterization of Ixodes scapularis antigens that elicit tick immunity using yeast surface display. Plos One 6(1), e15926 (2011
157. Marchal C, Schramm F, Kern A et al. Antialarmin effect of tick saliva during the transmission of Lyme disease. Infect. Immun. 79(2), 774-785 (2011
158. Chmelar J, Calvo E, Pedra JH, Francischetti IM, Kotsyfakis M. Tick salivary secretion as a source of antihemostatics. J. Proteomics 75(13), 3842-3854 (2012
159. Mejri N, Rutti B, Brossard M. Immunosuppressive effects of Ixodes ricinus tick saliva or salivary gland extracts on innate and acquired immune response of BALB/c mice. Parasitol. Res. 88(3), 192-197 (2002
160. Lieskovska J, Kopecky J. Effect of tick saliva on signalling pathways activated by TLR-2 ligand and Borrelia afzelii in dendritic cells. Parasite Immunol. 34(8-9), 421-429 (2012
161. Kern A, Collin E, Barthel C, Michel C, Jaulhac B, Boulanger N. Tick saliva represses innate immunity and cutaneous inflammation in a murine model of lyme disease. Vector Borne Zoonotic Dis. 11(10), 1343-1350 (2011
162. Guo X, Booth CJ, Paley MA et al. Inhibition of neutrophil function by two tick salivary proteins. Infect. Immun. 77(6), 2320-2329 (2009
163. Anguita J, Ramamoorthi N, Das S et al. Salp15, an Ixodes scapularis saliva protein, inhibits CD4+ T cell activation. Immunity 16, 849-859 (2002
164. Ramamoorthi N, Narasimhan S, Pal U et al. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436(7050), 573-577 (2005
165. Rosa P. Lyme disease agent borrows a practical coat. Nat. Med. 11(8), 831-832 (2005
166. Hojgaard A, Biketov SF, Shtannikov AV, Zeidner NS, Piesman J. Molecular identification of Salp15, a key salivary gland protein in the transmission of Lyme disease spirochetes, from Ixodes persulcatus and Ixodes pacificus (Acari: Ixodidae). J. Med. Entomol. 46(6), 1458-1463 (2009
167. Dai J, Wang P, Adusumilli S et al. Antibodies against a tick protein, Salp15, protect mice from the Lyme disease agent. Cell Host Microbe 6(5), 482-492 (2009
168. Schwalie PC, Schultz J. Positive selection in tick saliva proteins of the Salp15 family. J. Mol. Evol. 68(2), 186-191 (2009
169. Das S, Banerjee G, Deponte K, Marcantonio N, Kantor FS, Fikrig E. Salp25D, an Ixodes scapularis antioxidant, is 1 of 14 immunodominant antigens in engorged tick salivary glands. J. Infect. Dis. 184(8), 1056-1064 (2001
170. Narasimhan S, Sukumaran B, Bozdogan U et al. A tick antioxidant facilitates the Lyme disease agent's successful migration from the mammalian host to the arthropod vector. Cell Host Microbe 2(1), 7-18 (2007
171. Tyson K, Elkins C, Patterson H, Fikrig E, de Silva A. Biochemical and functional characterization of Salp20, an Ixodes scapularis tick salivary protein that inhibits the complement pathway. Insect Mol. Biol. 16(4), 469-479 (2007
172. Dai J, Narasimhan S, Zhang L, Liu L, Wang P, Fikrig E. Tick histamine release factor is critical for Ixodes scapularis engorgement and transmission of the Lyme disease agent. Plos Pathog. 6(11), e1001205 (2010
173. Schuijt TJ, Coumou J, Narasimhan S et al. A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the Lyme disease agent. Cell Host Microbe 10(2), 136-146 (2011
174. Konnai S, Yamada S, Imamura S et al. Identification of TROSPA homologue in Ixodes persulcatus Schulze, the specific vector for human Lyme borreliosis in Japan. Ticks Tick Borne Dis. 3(2), 75-77 (2012
175. Antunes S, Galindo RC, Almazan C et al. Functional genomics studies of Rhipicephalus (Boophilus) annulatus ticks in response to infection with the cattle protozoan parasite, Babesia bigemina. Int. J. Parasitol. 42(2), 187-195 (2012
176. Sauer JR, Hair JA. Morphology, Physiology and Biology of Ticks, Volume 1. Ellis Horwood Limited and John Wiley and Sons, NY, USA(1986
177. Sonenshine DE, Hynes WL, Ceraul SM, Mitchell R, Benzine T. Host blood proteins and peptides in the midgut of the tick Dermacentor variabilis contribute to bacterial control. Exp. Appl. Acarol. 36(3), 207-223 (2005
178. Christophides GK, Zdobnov E, Barillas-Mury C et al. Immunity-related genes and gene families in Anopheles gambiae. Science 298(5591), 159-165 (2002
179. Dimopoulos G, Casavant TL, Chang S et al. Anopheles gambiae pilot gene discovery project: Identification of mosquito innate immunity genes from expressed sequence tags generated from immune-competent cell lines. Proc. Natl Acad. Sci. USA 97(12), 6619-6624 (2000
180. Govind S, Nehm RH. Innate immunity in fruit flies: A textbook example of
181. Hoffmann JA, Reichhart JM. Drosophila innate immunity: An evolutionary perspective. Nat. Immunol. 3(2), 121-126 (2002
182. Saul A. The mosquito's innate sting. Nat. Med. 10(5), 455-457 (2004
183. Tanji T, Hu X, Weber AN, Ip YT. Toll and IMD pathways synergistically activate an innate immune response in Drosophila melanogaster. Mol. Cell Biol. 27(12), 4578-4588 (2007
184. Tanji T, Ip YT. Regulators of the Toll and Imd pathways in the Drosophila innate immune response. Trends Immunol. 26(4), 193-198 (2005
185. Valanne S, Wang JH, Ramet M. The Drosophila Toll signaling pathway. J. Immunol. 186(2), 649-656 (2011
186. Kopacek P, Hajdusek O, Buresova V, Daffre S. Tick innate immunity. Adv. Exp. Med. Biol. 708, 137-162 (2010
187. Hynes WL, Ceraul SM, Todd SM, Seguin KC, Sonenshine DE. A defensin-like gene expressed in the black-legged tick, Ixodes scapularis. Med. Vet. Entomol. 19(4), 339-344 (2005
188. Rudenko N, Golovchenko M, Edwards MJ, Grubhoffer L. Differential expression of Ixodes ricinus tick genes induced by blood feeding or Borrelia burgdorferi infection. J. Med. Entomol. 42(1), 36-41 (2005
189. Anderson JM, Sonenshine DE, Valenzuela JG. Exploring the mialome of ticks: An annotated catalogue of midgut transcripts from the hard tick, Dermacentor variabilis (Acari: Ixodidae). BMC Genomics 9, 552 (2008
190. Johns R, Ohnishi J, Broadwater A, Sonenshine DE, de Silva AM, Hynes WL. Contrasts in tick innate immune responses to Borrelia burgdorferi challenge: Immunotolerance in Ixodes scapularis versus immunocompetence in Dermacentor variabilis (Acari: Ixodidae). J. Med. Entomol. 38(1), 99-107. (2001
191. Johns R, Sonenshine DE, Hynes WL. Response of the tick Dermacentor variabilis (Acari: Ixodidae) to hemocoelic inoculation of Borrelia burgdorferi (Spirochetales). J. Med. Entomol. 37(2), 265-270. (2000
192. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev. 18(3), 484-509 (2005
193. Coleman AS, Rossmann E, Yang X et al. BBK07 immunodominant peptides as serodiagnostic markers of Lyme disease. Clin. Vaccine Immunol. 18(3), 406-413 (2011
194. Zhang X, Meltzer MI, Pena CA, Hopkins AB, Wroth L, Fix AD. Economic impact of Lyme disease. Emerg. Infect. Dis. 12(4), 653-660 (2006
195. Rosatte RC, Donovan D, Allan M et al. The control of raccoon rabies in Ontario Canada. proactive and reactive tactics, 1994-2007. J. Wildl. Dis. 45(3), 772-784 (2009
196. Rosatte RC, Donovan D, Davies JC et al. Aerial distribution of ONRAB baits as a tactic to control rabies in raccoons and striped skunks in Ontario, Canada. J. Wildl. Dis. 45(2), 363-374 (2009
197. Fikrig E, Barthold SW, Kantor FS, Flavell RA. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250, 553-556 (1990
198. Sigal LH, Zahradnik JM, Lavin P et al. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N. Engl. J. Med. 339(4), 216-222 (1998
199. Steere AC, Sikand VK, Meurice F et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N. Engl. J. Med. 339(4), 209-215 (1998
200. Tsao JI, Wootton JT, Bunikis J, Luna MG, Fish D, Barbour AG. An ecological approach to preventing human infection: Vaccinating wild mouse reservoirs intervenes in the Lyme disease cycle. Proc. Natl Acad. Sci. USA 101(52), 18159-18164 (2004
201. Bhattacharya D, Bensaci M, Luker KE et al. Development of a baited oral vaccine for use in reservoir-Targeted strategies against Lyme disease. Vaccine 29(44), 7818-7825 (2011
202. Scheckelhoff MR, Telford SR, Hu LT. Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs. Vaccine 24(11), 1949-1957 (2006
203. Del Rio B, Dattwyler RJ, Aroso M et al. Oral immunization with recombinant Lactobacillus plantarum induces a protective immune response in mice with Lyme disease. Clin. Vaccine Immunol. 15(9), 1429-1435 (2008
204. Gomes-Solecki MJ, Brisson DR, Dattwyler RJ. Oral vaccine that breaks the transmission cycle of the Lyme disease spirochete can be delivered via bait. Vaccine 24(20), 4440-4449 (2006
205. Meirelles Richer L, Aroso M, Contente- Cuomo T, Ivanova L, Gomes-Solecki M. Reservoir targeted vaccine for lyme borreliosis induces a yearlong, neutralizing antibody response to OspA in white-footed mice. Clin. Vaccine Immunol. 18(11), 1809-1816 (2011
206. Almazan C, Kocan KM, Bergman DK, Garcia-Garcia JC, Blouin EF, de la Fuente J. Identification of protective antigens for the control of Ixodes scapularis infestations using cDNA expression library immunization. Vaccine 21(13-14), 1492-1501 (2003
207. Merino O, Almazan C, Canales M et al. Targeting the tick protective antigen subolesin reduces vector infestations and pathogen infection by Anaplasma marginale and Babesia bigemina. Vaccine 29(47), 8575-8579 (2011
208. Merino O, Almazan C, Canales M et al. Control of Rhipicephalus (Boophilus) microplus infestations by the combination of subolesin vaccination and tick autocidal control after subolesin gene knockdown in ticks fed on cattle. Vaccine 29(12), 2248-2254 (2011
209. de la Fuente J, Ayoubi P, Blouin EF, Almazan C, Naranjo V, Kocan KM. Anaplasmosis: Focusing on host-vector-pathogen interactions for vaccine development. Ann. NY Acad. Sci. 1078, 416-423 (2006
210. Bensaci M, Bhattacharya D, Clark R, Hu HT. Oral vaccination with vaccinia virus expressing the tick antigen subolesin inhibits tick feeding and transmission of Borrelia burgdorferi vaccination. Vaccine 30(42), 6040-6046 (2012
211. Indest KJ, Howell JK, Jacobs MB, Scholl- Meeker D, Norris SJ, Philipp MT. Analysis of Borrelia burgdorferi vlsE gene expression and recombination in the tick vector. Infect. Immun. 69(11), 7083-7090 (2001
212. de Silva AM, Telford SR, Brunet LR, Barthold SW, Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J. Exp. Med. 183(1), 271-275 (1996
213. Almazan C, Kocan KM, Blouin EF, de la Fuente J. Vaccination with recombinant tick antigens for the control of Ixodes scapularis adult infestations. Vaccine 23(46-47), 5294-5298 (2005
214. de la Fuente J, Rodriguez M, Redondo M et al. Field studies and cost-effectiveness analysis of vaccination with Gavac against the cattle tick Boophilus microplus. Vaccine 16(4), 366-373 (1998
215. Cunha RC, Andreotti R, Leite FP. Rhipicephalus (Boophilus) microplus: Expression and characterization of Bm86-CG in Pichia pastoris. Rev. Bras. Parasitol. Vet. 20(2), 103-110 (2011
216. de la Fuente J, Rodriguez M, Montero C et al. Vaccination against ticks (Boophilus spp.). the experience with the Bm86-based vaccine Gavac. Genet. Anal. 15(3-5), 143-148 (1999
217. Odongo D, Kamau L, Skilton R et al. Vaccination of cattle with TickGARD induces cross-reactive antibodies binding to conserved linear peptides of Bm86 homologues in Boophilus decoloratus. Vaccine 25(7), 1287-1296 (2007